Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-031054
Filing Date
2004-06-16
Accepted
2004-06-16 14:52:06
Documents
1
Period of Report
2004-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - WARRANT EXERCISE rrd45556.html 4  
1 FORM 4 - WARRANT EXERCISE rrd45556.xml 4 11454
  Complete submission text file 0001181431-04-031054.txt   13381
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address CLAFLIN CAPITAL MANAGEMENT INC 10 LIBERTY SQ STE 300 BOSTON MA 02110 6174266505
CLAFLIN THOMAS M II (Reporting) CIK: 0001187889 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 04866105